Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


Discovery Chemistry & Drug Design Congress 2013

10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland



Bookmark and Share


Oxford Global Conferences are proud to present the Discovery Chemistry & Drug Design Congress taking place on 10 & 11 June in Geneva. This congress is the latest addition to our long-established 14th Annual Drug Discovery Summit. Focused on the latest breakthroughs in discovery chemistry, it will bring together the industry leaders in medicinal chemistry and drug design.

The discovery industry faces a decade of monumental change – stem cell research, gene therapy approvals, virtual R&D models and a growing focus on biological pipelines are just a few of the factors changing the way we approach drug discovery. Our expert speaker panel will explore the critical concerns in discovery chemistry today, while updating key decision makers on the latest developments in drug design.

Day One will feature presentations on lead optimisation, structure-activity relationships and fragment-based drug discovery. Our internationally renowned speakers will also discuss the latest developments in drug design, including anti-target modelling, advances in polypharmacology and structure based design.

The event will be co-located with the Innovation Driven Discovery Congress; a high-level meeting focused on novel approaches to drug discovery and collaborative working methods. Delegates will also be able to attend the co-located Drug Development Congress; a two stream event for those working at the forefront of research, development and translational medicine.



Further information
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Designer Cell Fate Switches Could Streamline Stem Cell Biology
Researchers develop new method of reprogramming cells between cell types in a more efficient way than before.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Soil Carbon Release Might Equal U.S. Emissions
Research suggests 55M tons of carbon will be release from soils by 2050, 17% higher than prjected emissions.
Inspiring Futuristic Innovation: Brain ‘Organoids’
Scientists create artificial brains, providing an advanced model for studying brain tumour development.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!